NEW DELHI: Bhabha Atomic Research Centre (BARC)-developed eye cancer therapy has been successfully used for the first time for the treatment of patients with ocular tumours in AIIMS-Delhi and the results of using Ruthenium 106 plaque for treatment of a patient with choroidal hemangioma (benign tumour in blood vessels) have been found to be satisfactory.
Union minister of state for atomic energy Jitendra Singh, who facilitated the collaboration between the Department of Atomic Energy (DAE) and Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, Delhi, informed about the breakthrough and lauded the BARC for developing the “simple and cost-effective therapy” for eye cancer patients.